|Articles|April 1, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-04-01-2005
- Volume 17
- Issue 4
Maintaining the Safety of EU Drugs
Author(s)Andrew Jackson
How important will anticounterfeiting measures become to protect the European pharma industry?
Advertisement
Articles in this issue
over 20 years ago
Nanotechnology Applications for Drug Deliveryover 20 years ago
Nanotech Not Big Enough for Pharma?over 20 years ago
Protecting Intellectual Property Prior to Commercializationover 20 years ago
Ion Exchange Resinates — The Technology Behind the Mysteryover 20 years ago
Defining The BordersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
